Sensydia Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $3M

  • Investors
  • 4

Sensydia General Information

Description

Developer of a portable, point-of-care hemodynamic measurement device designed to offer the treatment and management of patients with heart disease. The company's device helps in non-invasive monitoring of key cardiac performance metrics to reduce readmissions, lower the cost of care and improve outcomes for patients with heart disease, enabling medical staff to make real-time, objective, and informed decisions.

Contact Information

Website
www.sensydia.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1100 Glendon Avenue
  • Suite 1715
  • Los Angeles, CA 90024
  • United States
+1 (310)
Primary Industry
Monitoring Equipment
Other Industries
Diagnostic Equipment
Therapeutic Devices
Vertical(s)
Digital Health, Wearables & Quantified Self, Artificial Intelligence & Machine Learning, HealthTech
Corporate Office
  • 1100 Glendon Avenue
  • Suite 1715
  • Los Angeles, CA 90024
  • United States
+1 (310)

Sensydia Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensydia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 05-Jun-2023 $3M Completed Generating Revenue
4. Later Stage VC (Series D) 09-May-2023 Completed Generating Revenue
3. Later Stage VC (Series C) 18-Aug-2020 Completed Generating Revenue
2. Early Stage VC (Series B) 02-Aug-2017 $3.73M $5.73M Completed Generating Revenue
1. Early Stage VC (Series A) 16-Mar-2016 $2M $2M Completed Generating Revenue
To view Sensydia’s complete valuation and funding history, request access »

Sensydia Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D2
Series D1
Series C
Series B 5,402,000 $0.000010 $0.04 $0.69 $0.69 1x $0.69 13.93%
Series A 5,630,240 $0.000010 $0.02 $0.35 $0.35 1x $0.35 14.51%
To view Sensydia’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sensydia Patents

  • 2

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

Sensydia Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230329563-A1 Phonocardiogram (pcg) signal processing systems and methods for determining cardiac tissue and valvular blood flow parameters Pending 18-Apr-2022
US-20220304631-A1 Multisensor pulmonary artery and capillary pressure monitoring system Inactive 29-Mar-2021

Sensydia Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensydia Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institutes of Health Government
Orlando Health Ventures Corporate Venture Capital Minority
Colle Capital Partners Venture Capital Minority
Frontier Venture Capital Venture Capital Minority
To view Sensydia’s complete investors history, request access »

Ready to get started?

Request a free trial

Sensydia FAQs

  • When was Sensydia founded?

    Sensydia was founded in 2015.

  • Where is Sensydia headquartered?

    Sensydia is headquartered in Los Angeles, CA.

  • What is the size of Sensydia?

    Sensydia has 7 total employees.

  • What industry is Sensydia in?

    Sensydia’s primary industry is Monitoring Equipment.

  • Is Sensydia a private or public company?

    Sensydia is a Private company.

  • What is Sensydia’s current revenue?

    The current revenue for Sensydia is .

  • How much funding has Sensydia raised over time?

    Sensydia has raised $17.9M.

  • Who are Sensydia’s investors?

    National Institutes of Health, Orlando Health Ventures, Colle Capital Partners, and Frontier Venture Capital have invested in Sensydia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »